风湿免疫科指南

订阅

MedSci主页 / 所有栏目 / 风湿免疫科指南

2016 EULAR循证建议：系统性红斑狼疮和／或抗磷脂综合征女性患者计划生育，辅助生殖，妊娠和更年期管理及健康

2016-08-04 欧洲抗风湿病联盟 Ann Rheum Dis. 2016 Jul 25.

系统性红斑狼疮抗磷脂综合征

2016年7月，欧洲抗风湿病联盟(EULAR)发布了系统性红斑狼疮和／或抗磷脂综合征女性患者计划生育，辅助生殖，妊娠和更年期管理及健康建议，建议涉及的内容包括：优生咨询和危险分层，避孕措施，生育能力下降的危险因素，维持生育能力，人工授精，系统性红斑狼疮疾病活动期孕产妇生物标志物检测，孕期监测，药物预防，妊娠期辅助治疗，更年期激素替代疗法，恶性肿瘤筛查，HPV疫苗接种。

中文标题：

2016 EULAR循证建议：系统性红斑狼疮和／或抗磷脂综合征女性患者计划生育，辅助生殖，妊娠和更年期管理及健康

英文标题：

EULAR recommendations for women’s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome

发布机构：

欧洲抗风湿病联盟

发布日期：

2016-08-04

简要介绍：

2016年7月，欧洲抗风湿病联盟(EULAR)发布了系统性红斑狼疮和／或抗磷脂综合征女性患者计划生育，辅助生殖，妊娠和更年期管理及健康建议，建议涉及的内容包括：优生咨询和危险分层，避孕措施，生育能力下降的危险因素，维持生育能力，人工授精，系统性红斑狼疮疾病活动期孕产妇生物标志物检测，孕期监测，药物预防，妊娠期辅助治疗，更年期激素替代疗法，恶性肿瘤筛查，HPV疫苗接种。

相关资料下载：
[AttachmentFileName(sort=100, fileName=2016 EULAR循证建议：系统性红斑狼疮和／或抗磷脂综合征女性患者计划生育，辅助生殖，妊娠和更年期管理及健康)] GetToolGuiderByIdResponse(projectId=1, id=6a9d61c0012a9579, title=2016 EULAR循证建议：系统性红斑狼疮和／或抗磷脂综合征女性患者计划生育，辅助生殖，妊娠和更年期管理及健康, enTitle=EULAR recommendations for women’s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome, guiderFrom=Ann Rheum Dis. 2016 Jul 25., authorId=null, author=, summary=2016年7月，欧洲抗风湿病联盟(EULAR)发布了系统性红斑狼疮和／或抗磷脂综合征女性患者计划生育，辅助生殖，妊娠和更年期管理及健康建议，建议涉及的内容包括：优生咨询和危险分层，避孕措施，生育能力下降的危险因素，维持生育能力，人工授精，系统性红斑狼疮疾病活动期孕产妇生物标志物检测，孕期监测，药物预防，妊娠期辅助治疗，更年期激素替代疗法，恶性肿瘤筛查，HPV疫苗接种。 , cover=, journalId=null, articlesId=null, associationId=258, associationName=欧洲抗风湿病联盟, associationIntro=null, copyright=0, guiderPublishedTime=Thu Aug 04 10:29:27 CST 2016, originalUrl=, linkOutUrl=, content=2016年7月，欧洲抗风湿病联盟(EULAR)发布了系统性红斑狼疮和／或抗磷脂综合征女性患者计划生育，辅助生殖，妊娠和更年期管理及健康建议，建议涉及的内容包括：优生咨询和危险分层，避孕措施，生育能力下降的危险因素，维持生育能力，人工授精，系统性红斑狼疮疾病活动期孕产妇生物标志物检测，孕期监测，药物预防，妊娠期辅助治疗，更年期激素替代疗法，恶性肿瘤筛查，HPV疫苗接种。 <div><br> 拓展指南：<strong>与<font color=red>系统性红斑狼疮</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=6a9d61c0012a9579" title="2016 EULAR循证建议：系统性红斑狼疮和／或抗磷脂综合征女性患者计划生育，辅助生殖，妊娠和更年期管理及健康" target=_blank>2016 EULAR循证建议：系统性红斑狼疮和／或抗磷脂综合征女性患者计划生育，辅助生殖，妊娠和更年期管理及健康</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=beb1e1c001139aa2" title="中国成人系统性红斑狼疮相关肺动脉高压诊治共识" target=_blank>中国成人系统性红斑狼疮相关肺动脉高压诊治共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=f01b21c00111a226" title="风湿免疫疾病( 系统性红斑狼疮) 超药品说明书用药专家共识" target=_blank>风湿免疫疾病( 系统性红斑狼疮) 超药品说明书用药专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=2a2421c0010e9227" title="2014 糖皮质激素在系统性红斑狼疮患者合理应用的专家共识" target=_blank>2014 糖皮质激素在系统性红斑狼疮患者合理应用的专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=088be1c001066608" title="2014 靶向治疗系统性红斑狼疮：国际工作组推荐建议" target=_blank>2014 靶向治疗系统性红斑狼疮：国际工作组推荐建议</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E7%B3%BB%E7%BB%9F%E6%80%A7%E7%BA%A2%E6%96%91%E7%8B%BC%E7%96%AE" target=_blank>有关系统性红斑狼疮更多指南</a></ul></div>, tagList=[TagDto(tagId=648, tagName=系统性红斑狼疮), TagDto(tagId=32989, tagName=抗磷脂综合征)], categoryList=[CategoryDto(categoryId=15, categoryName=风湿免疫科, tenant=100), CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=2, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7959, appHits=687, showAppHits=6, pcHits=5535, showPcHits=2719, likes=193, shares=34, comments=5, approvalStatus=1, publishedTime=Thu Aug 04 10:29:27 CST 2016, publishedTimeString=2016-08-04, pcVisible=1, appVisible=1, editorId=5295957, editor=lili, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=lili, createdTime=Thu Aug 04 10:29:27 CST 2016, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 05:14:31 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2016 EULAR循证建议：系统性红斑狼疮和／或抗磷脂综合征女性患者计划生育，辅助生殖，妊娠和更年期管理及健康)])
2016 EULAR循证建议：系统性红斑狼疮和／或抗磷脂综合征女性患者计划生育，辅助生殖，妊娠和更年期管理及健康
下载请点击：
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1056580, encodeId=e4221056580d0, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Thu Sep 30 16:41:03 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056579, encodeId=ef7910565e9bc, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Thu Sep 30 16:40:56 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977545, encodeId=b59e9e75451e, content=有翻译的啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecaa5535685, createdName=ms6000001833738705, createdTime=Mon Jun 28 11:40:18 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977544, encodeId=00479e7544ca, content=有翻译的啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecaa5535685, createdName=ms6000001833738705, createdTime=Mon Jun 28 11:40:11 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=122474, encodeId=c5751224e4d1, content=没有梅斯医学指导还真不知道这些，得好好学习呀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sun Sep 11 11:25:00 CST 2016, time=2016-09-11, status=1, ipAttribution=)]
    2021-09-30 13f0c37dm61暂无昵称

    谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1056580, encodeId=e4221056580d0, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Thu Sep 30 16:41:03 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056579, encodeId=ef7910565e9bc, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Thu Sep 30 16:40:56 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977545, encodeId=b59e9e75451e, content=有翻译的啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecaa5535685, createdName=ms6000001833738705, createdTime=Mon Jun 28 11:40:18 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977544, encodeId=00479e7544ca, content=有翻译的啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecaa5535685, createdName=ms6000001833738705, createdTime=Mon Jun 28 11:40:11 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=122474, encodeId=c5751224e4d1, content=没有梅斯医学指导还真不知道这些，得好好学习呀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sun Sep 11 11:25:00 CST 2016, time=2016-09-11, status=1, ipAttribution=)]
    2021-09-30 13f0c37dm61暂无昵称

    谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1056580, encodeId=e4221056580d0, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Thu Sep 30 16:41:03 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056579, encodeId=ef7910565e9bc, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Thu Sep 30 16:40:56 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977545, encodeId=b59e9e75451e, content=有翻译的啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecaa5535685, createdName=ms6000001833738705, createdTime=Mon Jun 28 11:40:18 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977544, encodeId=00479e7544ca, content=有翻译的啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecaa5535685, createdName=ms6000001833738705, createdTime=Mon Jun 28 11:40:11 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=122474, encodeId=c5751224e4d1, content=没有梅斯医学指导还真不知道这些，得好好学习呀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sun Sep 11 11:25:00 CST 2016, time=2016-09-11, status=1, ipAttribution=)]
    2021-06-28 ms6000001833738705

    有翻译的啊

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1056580, encodeId=e4221056580d0, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Thu Sep 30 16:41:03 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056579, encodeId=ef7910565e9bc, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Thu Sep 30 16:40:56 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977545, encodeId=b59e9e75451e, content=有翻译的啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecaa5535685, createdName=ms6000001833738705, createdTime=Mon Jun 28 11:40:18 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977544, encodeId=00479e7544ca, content=有翻译的啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecaa5535685, createdName=ms6000001833738705, createdTime=Mon Jun 28 11:40:11 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=122474, encodeId=c5751224e4d1, content=没有梅斯医学指导还真不知道这些，得好好学习呀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sun Sep 11 11:25:00 CST 2016, time=2016-09-11, status=1, ipAttribution=)]
    2021-06-28 ms6000001833738705

    有翻译的啊

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1056580, encodeId=e4221056580d0, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Thu Sep 30 16:41:03 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056579, encodeId=ef7910565e9bc, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Thu Sep 30 16:40:56 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977545, encodeId=b59e9e75451e, content=有翻译的啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecaa5535685, createdName=ms6000001833738705, createdTime=Mon Jun 28 11:40:18 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977544, encodeId=00479e7544ca, content=有翻译的啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecaa5535685, createdName=ms6000001833738705, createdTime=Mon Jun 28 11:40:11 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=122474, encodeId=c5751224e4d1, content=没有梅斯医学指导还真不知道这些，得好好学习呀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sun Sep 11 11:25:00 CST 2016, time=2016-09-11, status=1, ipAttribution=)]
    2016-09-11 1e10c84am36(暂无匿称)

    没有梅斯医学指导还真不知道这些，得好好学习呀

    0

相关指南

中国成人系统性红斑狼疮相关肺动脉高压诊治共识

中国系统性红斑狼疮研究协作组(CSTAR,Chinese SLE Treatment And Research Group) · 2015-02-01

风湿免疫疾病( 系统性红斑狼疮) 超药品说明书用药专家共识

广东省药学会 · 2014-09-25

2014 糖皮质激素在系统性红斑狼疮患者合理应用的专家共识

中国系统性红斑狼疮研究协作组(CSTAR,Chinese SLE Treatment And Research Group) · 2014-06-03

2014 靶向治疗系统性红斑狼疮：国际工作组推荐建议

国外风湿免疫科相关专家小组 · 2014-04-16

2011 中国儿童系统性红斑狼疮诊疗建议

中华医学会儿科学分会免疫学组 · 2011-07-01

2010 EULAR 治疗有神经精神症状的系统性红斑狼疮患者的推荐意见

欧洲抗风湿病联盟(EULAR,The European League Against Rheumatism) · 2010-12-01